GB953107A - Veterinary compositions comprising 6?-methyl-17?-hydroxyprogesterone 17-acetate - Google Patents

Veterinary compositions comprising 6?-methyl-17?-hydroxyprogesterone 17-acetate

Info

Publication number
GB953107A
GB953107A GB25507/60A GB2550760A GB953107A GB 953107 A GB953107 A GB 953107A GB 25507/60 A GB25507/60 A GB 25507/60A GB 2550760 A GB2550760 A GB 2550760A GB 953107 A GB953107 A GB 953107A
Authority
GB
United Kingdom
Prior art keywords
compositions
steroid
estradiol
mixes
acetate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB25507/60A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of GB953107A publication Critical patent/GB953107A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/184—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/168—Steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C07F9/24—Esteramides
    • C07F9/2454—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2458—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic of aliphatic amines

Abstract

The invention comprises injectable pharmaceutical compositions comprising 6a -methyl-17a - hydroxy - progesterone - 17 - acetate, orally administrable compositions comprising the steroid, a sedative and, optionally, a diuretic, and the steroid and an estrogenic substance and veterinary compositions comprising the steroid and a carrier and, optionally, other therapeutic ingredients. Specified additional therapeutic substances are estrone, estradiol, estriol, ethinyl estradiol, estradiol cyclopentylpropionate and diethylstilbestrol (estrogenic substances); acetyl salicylic acid, N-acetyl-p-aminophenol, salicylamide and phencetin (analgesics); phenobarbitol, carbromal, reserpine and ectyluren (sedatives); ethoxzolamide, hydrochlorthiazide and acetazolamide (diuretics); mepazine, perphenazine and oxanamide (tranquiligus) and corisprodol, chlorzoxazone and phenaglycodol (muscle relaxants). The compositions may be in conventional forms e.g. tablets, capsules, pills, elixirs, suspensions, syrups, mixes with and pre-mixes for addition to animal and bird feed stuffs and may comprise conventional diluents, carriers and excipients. They have progestational activity. Specification 866,381 is referred to.
GB25507/60A 1959-08-11 1960-07-21 Veterinary compositions comprising 6?-methyl-17?-hydroxyprogesterone 17-acetate Expired GB953107A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83290959A 1959-08-11 1959-08-11
US3933360A 1960-06-28 1960-06-28

Publications (1)

Publication Number Publication Date
GB953107A true GB953107A (en) 1964-03-25

Family

ID=26716024

Family Applications (1)

Application Number Title Priority Date Filing Date
GB25507/60A Expired GB953107A (en) 1959-08-11 1960-07-21 Veterinary compositions comprising 6?-methyl-17?-hydroxyprogesterone 17-acetate

Country Status (3)

Country Link
BE (1) BE593957A (en)
FR (2) FR168M (en)
GB (1) GB953107A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767708B2 (en) 1998-11-04 2010-08-03 Schering-Plough Animal Health Corp. Growth stimulant compositions

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767708B2 (en) 1998-11-04 2010-08-03 Schering-Plough Animal Health Corp. Growth stimulant compositions
US7999005B2 (en) 1998-11-04 2011-08-16 Schering-Plough Animal Health Corporation Growth stimulant compositions

Also Published As

Publication number Publication date
FR168M (en) 1961-02-13
BE593957A (en) 1961-02-10
FR169M (en) 1961-02-13

Similar Documents

Publication Publication Date Title
US3568828A (en) Modified sequential oral contraceptive
US3409721A (en) Oral dosage system effective to control the reproduction cycle
US20040180867A1 (en) Low dose estrogen interrupted hormone replacement therapy
GB1490099A (en) Contraceptive method and pack
HK17486A (en) Nonapeptide and decapeptide derivatives of luteinizing hormone releasing hormone,their preparation and pharmaceutical compositions containing them
GORDAN et al. Methylandrostenediol: a protein-anabolic steroid with little androgenic activity
GB953107A (en) Veterinary compositions comprising 6?-methyl-17?-hydroxyprogesterone 17-acetate
Stone The radioactive compounds in various tissues of the ovariectomised mouse following the systemic administration of tritiated oestradiol and oestrone
BG101427A (en) Competitive progesterone antagonists for regulating female fertility as required
Morris et al. Post-coital oral contraception
FUENZALIDA Absorption of steroids from subcutaneously implanted tablets of the pure hormone and of the hormone mixed with cholesterol
NZ184731A (en) Analogues of luteninising hormone releasing factor; pharmaceutical and veterinary compositions
US4171358A (en) Novel contraceptive method
Lyon et al. Duration of sensitivity of the endometrium during lactation in the rat
Dorfman et al. Biological activity of various steroids including B-norsteroids
Nishino et al. The sialic acid content in mouse female reproductive organs as a quantitative parameter for testing the estrogenic and antiestrogenic effect, antiestrogenic depot effect, and dissociated effect of estrogens on the uterus and vagina
ES283585A1 (en) A procedure for the preparation of a therapeutic composition (Machine-translation by Google Translate, not legally binding)
Tyler Studies of" mini-micro" contraceptive doses of a new progestrogen
Teter et al. A comparative study of the estrogenic potential of two synthetic estrogens (mestranol and ethinylestradiol)
WIED et al. 9α-BROMO-11-KETOPROGESTERONE. ANOTHER NEW ORALLY EFFECTIVE SUBSTANCE WITH PROGESTATIONAL ACTIVITY
GB1260463A (en) 11beta-BROMO-19-NOR-STEROIDS
Singh et al. Effect of intravaginal instillation of some non-steroidal oral antifertility agents on pregnancy in rats
GB1116795A (en) An oral contraceptive preparation
ATKINSON A review of experimental and clinical trials of stilbestrol
Sud et al. Effect of melengestrol acetate on the organ weight & the mammary lobulo-alveolar development in rats